Updated: July 12, 2026

Funding raised
€134M
About the program
Program type
Investment stage
Investment focus areas
Description
Doubled from DTS1/DTS2 (~€77M each), 12% above revised €120M target. €1B+ AUM across all vehicles. Deep research institution partnerships with PSL, INRIA, CNRS, Max Planck Foundation. Three pillars: computing, industry, and life sciences. Exit to Eli Lilly (Mablink).